Recurrent chromosomal imbalances and structurally abnormal breakpoints within complex karyotypes of malignant peripheral nerve sheath tumour and malignant triton tumour: A cytogenetic and molecular cytogenetic study

Journal of Clinical Pathology

Volumn 57, Issue 11, 2004, Pages 1172-1178

  Bridge Jr , R S ^a   Bridge, J A ^a   Neff, J R ^a   Naumann, S ^a   Althof, P ^a   Bruch, L A ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; NEUROFIBROMIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CHROMOSOME 11Q; CHROMOSOME 19Q; CHROMOSOME 1P; CHROMOSOME 20Q; CHROMOSOME 22Q; CHROMOSOME 4Q; CHROMOSOME 7P; CHROMOSOME ANALYSIS; CHROMOSOME MARKER; CLINICAL ARTICLE; CYTOGENETICS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC ANALYSIS; HUMAN; KARYOTYPE; KARYOTYPING; MALE; MALIGNANT TRITON TUMOR; MOLECULAR GENETICS; NERVE SHEATH TUMOR; NEUROFIBROMATOSIS; PERIPHERAL NERVE SHEATH TUMOR; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; FEMALE; GENE AMPLIFICATION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; MALE; MIDDLE AGED; NERVE SHEATH NEOPLASMS; NEUROFIBROMATOSIS 1; RHABDOMYOSARCOMA; TRANSLOCATION, GENETIC;

EID: 8444226791     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2004.019026     Document Type: Article

References (36)

1. King AA, DeBaun MR, Riccardi VM, et al. Malignant peripheral nerve sheath tumors in neurofibromatosis 1. Am J Med Genet 2000;93:388-92.
2. Woodruff JM, Chernick NL, Smith MC, et al. Peripheral nerve tumors with rhabdomyosarcomatous differentiation (malignant "triton" tumors). Cancer 1973;32:426-39.
3. Woodruff JM, Kourea HP, Louis DN, et al. Malignant peripheral nerve sheath tumor (MPNST). In: Kleihues P, Cavenee WK, eds. WHO classification of tumours: pathology and genetics. Tumours of the nervous system. Lyon, France: IARC Press, 2000:172-3.
4. Bridge JA. Soft tissue sarcomas. In: Wolman SR, Sells S, eds. Cytogenetic markers of human disease. Clifton, NJ: Humana Press, 1997:425-59.
5. Travis JA, Sandberg AA, Neff JR, et al. Cytogenetic findings in malignant triton tumor. Genes Chromosomes Cancer 1994;9:1-7.
6. McComb EN, McComb RD, DeBoer JM, et al. Cytogenetic analysis of a malignant triton tumor and a malignant peripheral nerve sheath tumor and a review of the literature. Cancer Genet Cytogenet 1996;91:8-12.
7. Plaat BE, Molenaar WM, Mastik MF, et al. Computer-assisted cytogenetic analysis of 51 malignant peripheral-nerve-sheath tumors: sporadic vs. neurofibromatosis-type-1-associated malignant schwannomas. Int J Cancer 1999;83:171-8.
8. Mertens F, Dal Cin P, De Wever I, et al. Cytogenetic characterization of peripheral nerve sheath tumours: a report of the CHAMP study group. J Pathol 2000;190:31-8.
9. Haddadin MH, Hawkins AL, Long P, et al. Cytogenetic study of malignant triton tumor: a case report. Cancer Genet Cytogenet 2003;144:100-5.
10. Gil Z, Fliss DM, Voskoboimik N, et al. Two novel translocations, t(2;4)(q35;q31) and t(X;12)(q22;q24), as the only karyolypic abnormalities in a malignant peripheral nerve sheath tumor of the skull base. Cancer Genet Cytogenet 2003;145:139-43.
11. Mawrin C, Kirches E, Boltze C, et al, Immunohistochemical and molecular analysis of p53, RB, and PTEN in malignant peripheral nerve sheath tumors. Virchows Arch 2002;440:610-15.
12. Scheithauer BW, Woodruff JM, Erlandson RA. Primary malignant tumors of peripheral nerve. In: Tumors of the peripheral nervous system. Atlas of tumor pathology, 3rd series, fascicle 24. Washington, DC: Armed Forces Institute of Pathology, 1999:303-72.
13. Mitelman F, ed. ISCN: an international system for human cytogenetic nomenclature. Basel: Karger, 1995.
14. Safar A, Nelson M, Neff JR, et al. Recurrent anomalies of 6q25 in chondromyxoid fibroma. Hum Pathol 2000;31:306-11.
15. Safar A, Wickert R, Nelson M, et al. Characterization of a variant SYT/SSX1 synovial sarcoma fusion transcript. Mol Diagn Pathol 1998;7:283-7.
16. Bernards A. Neurofibromatosis type 1 and Ras-mediated signaling: filling in the GAPs. Biochim Biophys Acta 1995;1242:43-59.
17. Shen MH, Harper PS, Upadhyaya M. Molecular genetics of neurofibromatosis type 1 (NF1). J Med Genet 1996;33:2-17.
18. Doom P, Molenar W, Buter J, et al. Malignant peripheral nerve sheath tumors in patients with and without neurofibromatosis. Eur J Surg Oncol 1995;21:78-82.
19. Bridge JA, Sandberg AA. Cytogenetic and molecular genetic techniques as adjunctive approaches in the diagnosis of bone and soft tissue tumors. Skeletal Radiol 2000;29:249-58.
20. Jeon I-S, Davis JN, Braun BS, et al. A variant Ewing's sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1. Oncogene 1995;10:1229-34.
21. Nicolaides NC, Papodopoulos N, Liu B, et al. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 1994;371:75-80.
22. Hamilton SR, Liu B, Parsons RE, et al. The molecular bosis of Turcot's syndrome. N Engl J Med 1995;332:839-47.
23. LeBeau MM, Westbrook CA, Diaz MO, et al. Evidence for two distinct c-src loci on human chromosomes 1 and 20. Nature 1984;312:70-1.
24. Irby RB, Mao W, Coppola D, et al. Activating SRC mutation in a subset of advanced human colon cancers. Nat Genet 1999;21:187-90.
25. Rouleau GA, Merel P, Lutchman M, et al. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 1993;363:515-21.
26. Rey JA, Bello MJ, Kusak ME, et al. Involvement of 22q12 in a neurofibrosarcoma in neurofibromatosis type I. Cancer Genet Cytogenet 1993;66:28-32.
27. Perry A, Kunz SN, Ruller CE, et al. Differential NF1, p16, and EGFR patterns by interphase cytogenetics (FISH) in malignant peripheral nerve sheath tumor (MPNST) and morphologically similar spindle cell neoplasms. J Neuropathol Exp Neurol 2002;61:702-9.
28. Kourea HP, Orlow I, Scheithauer BW, et al. Deletion of the INK4a gene occurs in malignant peripheral nerve sheath tumors but not in neurofibromas. Am J Pathol 1999;155:1855-60.
29. Nielsen GP, Stemmer-Rachmaninov AO, Ino Y, et al. Malignant transformation of neurofibromas in neurofibromatosis 1 is associated with CDKN2A/p16 inactivation. Am J Pathol 1999;155:1879-84.
30. Leguis E, Marchuk DA, Collins FS, et al. Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis. Nat Genet 1993;3:122-6.
31. Menon AG, Anderson KM, Riccardi VM, et al. Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis. Proc Natl Acad Sci U S A 1990;87:5435-9.
32. Legius E, Dierrick H, Wu R, et al. TP53 mutations are frequent in malignant NF1 tumors. Genes Chromosomes Cancer 1994;10:250-5.
33. Lothe RA, Slettan A, Saeter G, et al. Alterations at chromosome 17 loci in peripheral nerve sheath tumors. J Neuropathol Exp Neurol 1995;54:65-73.
34. Weeber EJ, Sweatt JD. Molecular neurobiology of human cognition. Neuron 2002;33:845-8.
35. Saito T, Seki N, Matsuda Y, et al. Identification of the human ERK gene as a putative receptor tyrosine kinase and its chromosomal localization to 1 p36. 1: a comparative mapping of human, mouse, and rat chromosomes. Genomics 1995;26:382-4.
36. O'Sullivan MJ, Kyriakos M, Zhu X, et al. Malignant peripheral nerve sheath tumors with t(X; 18). A pathologic and molecular genetic study. Mod Pathol 2000;13:1253-63.